Cited 0 times in
Comparison of therapeutic efficacy between bortezomib and combination treatment of prednisolone and mycophenolate mofetil on nephritis in NZB/WF1 mice.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김범석 | - |
dc.contributor.author | 이상원 | - |
dc.date.accessioned | 2015-04-23T17:06:36Z | - |
dc.date.available | 2015-04-23T17:06:36Z | - |
dc.date.issued | 2010 | - |
dc.identifier.issn | 0392-856X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/101838 | - |
dc.description.abstract | OBJECTIVES: We investigated the efficacy of bortezomib on nephritis in NZB/WF1 mice, and compared it to prednisolone (PL) and mycophenolate mofetil (MMF) treatment. METHODS: Twenty-three NZB/WF1 mice were divided into four groups (untreated, 0.1 mg/kg and 1 mg/kg bortezomib-treated, and PL plus MMF-treated). Proteinuria, glomerular IgG deposition, cellular proliferation and histologic damages were evaluated. RESULTS: In comparison with the untreated mice, 1 mg/kg bortezomib significantly reduced proteinuria and attenuated glomerular IgG deposition, cellular proliferation and histologic damages similar to PL plus MMF. 0.1 mg/kg bortezomib significantly improved glomerular IgG deposition and histologic damages except proteinuria or cellular proliferation compared to untreated mice. PL plus MMF showed significantly greater inhibition of cellular proliferation and histologic damage than 1 mg/kg bortezomib. CONCLUSIONS: We found that 1 mg/kg bortezomib significantly improved lupus nephritis in NZB/WF1 mice. However, its efficacy did not exceed PL plus MMF treatment. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 393~396 | - |
dc.relation.isPartOf | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Boronic Acids/pharmacology* | - |
dc.subject.MESH | Bortezomib | - |
dc.subject.MESH | Cell Division | - |
dc.subject.MESH | Disease Models, Animal | - |
dc.subject.MESH | Drug Therapy, Combination | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Glucocorticoids/pharmacology | - |
dc.subject.MESH | Immunoglobulin G/metabolism | - |
dc.subject.MESH | Immunosuppressive Agents/pharmacology | - |
dc.subject.MESH | Kidney Glomerulus/immunology | - |
dc.subject.MESH | Kidney Glomerulus/pathology | - |
dc.subject.MESH | Lupus Nephritis/drug therapy* | - |
dc.subject.MESH | Lupus Nephritis/immunology | - |
dc.subject.MESH | Lupus Nephritis/pathology | - |
dc.subject.MESH | Mice | - |
dc.subject.MESH | Mice, Inbred NZB | - |
dc.subject.MESH | Mycophenolic Acid/analogs & derivatives* | - |
dc.subject.MESH | Mycophenolic Acid/pharmacology | - |
dc.subject.MESH | Prednisolone/pharmacology* | - |
dc.subject.MESH | Protease Inhibitors/pharmacology | - |
dc.subject.MESH | Proteinuria/drug therapy | - |
dc.subject.MESH | Proteinuria/immunology | - |
dc.subject.MESH | Proteinuria/pathology | - |
dc.subject.MESH | Pyrazines/pharmacology* | - |
dc.title | Comparison of therapeutic efficacy between bortezomib and combination treatment of prednisolone and mycophenolate mofetil on nephritis in NZB/WF1 mice. | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | S. Lee | - |
dc.contributor.googleauthor | B. Kim | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00488 | - |
dc.contributor.localId | A02824 | - |
dc.relation.journalcode | J00555 | - |
dc.identifier.eissn | 1593-098X | - |
dc.identifier.pmid | 20497633 | - |
dc.identifier.url | http://www.clinexprheumatol.org/abstract.asp?a=595 | - |
dc.subject.keyword | Bortezomib | - |
dc.subject.keyword | lupus nephritis | - |
dc.subject.keyword | NZB/WF1 mice | - |
dc.contributor.alternativeName | Kim, Beom Seok | - |
dc.contributor.alternativeName | Lee, Sang Won | - |
dc.contributor.affiliatedAuthor | Kim, Beom Seok | - |
dc.contributor.affiliatedAuthor | Lee, Sang Won | - |
dc.citation.volume | 28 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 393 | - |
dc.citation.endPage | 396 | - |
dc.identifier.bibliographicCitation | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, Vol.28(3) : 393-396, 2010 | - |
dc.identifier.rimsid | 54643 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.